옛 화면은 좌우로 밀어 볼 수 있습니다.

Publications

Projects :
Published Dates :
Select All
Identification and functional study of genetic polymorphisms in cyclic nucleotide phosphodiesterase 3A (PDE3A) (cPMTb)
Ann Hum Genet. 85(2):80-91 / 2021.03 [LINK]
Repression of PPARγ reduces the ABCG2-mediated efflux activity of M2 macrophages (cPMTb)
Int J Biochem Cell Biol. 130:105895 / 2021.01 [LINK]
Identification and functional characterization of CYP4V2 genetic variants exhibiting decreased activity of lauric acid metabolism (cPMTb)
Ann Hum Genet. 84(5):400-411 / 2020.09 [LINK]
Increased hepatic acylcarnitines after oral administration of amiodarone in rats (cPMTb)
J Appl Toxicol. 40(7):1004-1013 / 2020.07 [LINK]
Survey of physicians' views on the clinical implementation of pharmacogenomics-based personalized therapy (cPMTb)
Transl Clin Pharmacol. 28(1):34-42 / 2020.03 [LINK]
Inhibition of 20-hydroxyeicosatetraenoic acid (20-HETE) glucuronidation by non-steroidal anti-inflammatory drugs in human liver microsomes and recombinant UDP-glucuronosyltransferase enzymes (cPMTb)
Prostaglandins Leukot Essent Fatty Acids. 153:10205 / 2020.02 [LINK]
A new population pharmacokinetic model for vancomycin in patients with variable renal function: Therapeutic drug monitoring based on extended covariate model using CKD‐EPI estimation (cPMTb)
J Clin Pharm Ther. 44(5):750-759 / 2019.10 [LINK]
Rifampin induces expression of P-glycoprotein on the macrophages, causing decrease intra-macrophage concentration of prothionamide (cPMTb)
J Pharm Sci. 108(9):3106-3111 / 2019.09 [LINK]
Antiepileptic drug-induced severe cutaneous adverse reactions and HLA alleles: A report of five cases with lymphocyte activation test (cPMTb)
Transl Clin Pharmacol. 27(2):64-68 / 2019.06 [LINK]
Influences of cytochrome b5 expression and its genetic variant on the activity of CYP2C9, CYP2C19 and CYP3A4 (cPMTb)
Drug Metab Pharmacokinet.34(3):201-208 / 2019.06 [LINK]